Oklo is turning its advanced nuclear reactor plans into execution. Its Groves isotope facility in Texas reached criticality on August 5, which Oklo calls the fastest greenfield-to-criticality run for a privately funded reactor in history. Meta signed an agreement letting it prepay for power from a planned 1.2GW Oklo campus in Ohio, the first Aurora powerhouse at Idaho National Laboratory is targeted for 2028, and Oklo holds $3.0B of cash and securities. x.com 

The DOE's approval of the final safety analysis for Oklo's Groves isotope test reactor is a good high-beta nuclear milestone, especially with Barron's flagging its first reactor going live this month. It remains project and regulatory hype rather than revenue. x.com 

Oklo is now rated Neutral with an $83 December 2026 target because the market prices its 15.2 GW pipeline with more confidence than its contracts support. Only Meta's 1.2 GW agreement is binding; most of the rest are letters of intent that hinge on Oklo proving Aurora can be licensed, built and run at a competitive cost. The target applies 20x 2040 EV/EBITDA discounted at 12.5%, assumes 5.1 GW by 2040 and gives fuel and isotopes no value. HALEU fuel scarcity and SMR rivals add risk. x.com 

Oklo is a generational bet that could become a $200-500 billion company in 10 years if it executes modular nuclear at scale, though meaningful reactor revenue won't come until 2028-2030. Its $2.5 billion of cash covers 25-plus years of runway, the NRC accepted its design criteria in 15 days, NVIDIA is helping validate fuel, Atomic Alchemy's license enables isotope revenue from late 2026, and Meta's 1.2 GW campus and a potential Centrus HALEU venture secure customer and fuel. x.com 

Oklo and NuScale look attractive at current levels as big players start taking small modular reactors seriously. At over $10B market caps the pre-revenue pure plays were wildly overvalued, but at about $4B and $8B it's a different story. Goldman Sachs added SMRs to its uranium models in May 2026, lifting its prior forecast 17%. It may be too early, but the SMR market looks very investable long term. x.com 

Oklo has no revenue or operating reactors and is burning $570M in free cash flow. Its executives have also been selling shares; the stock's steep decline looks like capital markets disciplining a speculative business. x.com  x.com 

Oklo has received another approval, which is good news for the stock. x.com 

Oklo's acquisition of Creative Engineers Inc. should speed its first Aurora reactor and cut execution risk. CEI, the global leader in liquid-metal nuclear engineering, brings sodium handling, testing and manufacturing in-house for Aurora's sodium-cooled design, and has five straight years of positive free cash flow. Oklo sells power via long-term PPAs to clients like Meta for decades of recurring cash flow. Its $2.5 billion of cash covers about 30 years of burn, removing dilution pressure. x.com 

Oklo's new $1 billion at-the-market offering, reported by @StockSavvyShay, is a reminder that a nuclear reactor takes 10-15 years and a lot of capital to build. Investors may not be ready for that ride. x.com 

Oklo's Aurora reactor could turn AI's power bottleneck into a repeatable commercial business if Aurora-INL starts on schedule and later units become cheaper to build. Groves reached first criticality, but its isotope reactor does not prove Aurora's economics. Fuel supply, capital needs and dilution remain major hurdles; a tenfold gain would require a large operating fleet and billions in sustainable revenue and cash flow. x.com